Muller Lorenz 4
4 · Milestone Pharmaceuticals Inc. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Milestone (MIST) CCO Muller Lorenz Receives Equity Awards
What Happened
Muller Lorenz, Chief Commercial Officer of Milestone Pharmaceuticals (MIST), received two equity awards on February 2, 2026: 204,000 derivative awards (likely stock options) and 136,000 restricted stock units (RSUs). Both grants show an acquisition price of $0 and a reported total value of $0 on the Form 4 because these are compensation awards rather than open‑market purchases.
Key Details
- Transaction date: 2026-02-02; Form 4 filed 2026-02-04 (appears timely).
- Grants: 204,000 (derivative award, listed at $0) and 136,000 RSUs (each RSU = 1 contingent common share).
- Shares owned after the transaction: Not specified in the filing.
- Vesting for the 204,000 derivative award: 25% vests on Feb 2, 2027, then 1/36th of the remainder vests monthly thereafter (footnote F1).
- Vesting for the 136,000 RSUs: 25% vests each Feb 2 of 2027, 2028, 2029 and 2030 (footnote F3).
- Transaction code: A = Award/Grant. No 10b5-1 plan, tax‑withholding, or cashless sale noted.
Context
These awards are company compensation (not open‑market purchases or sales). RSUs convert to actual shares only as they vest; the derivative award follows a staggered vesting schedule. Because no cash changed hands at grant, the filing reports $0 value on the transaction line — intrinsic value (if any) depends on Milestone’s future stock price and whether the derivative is an option-type award.
Insider Transaction Report
- Award
Employee Stock Option (right to buy)
[F1]2026-02-02+204,000→ 204,000 totalExercise: $1.97Exp: 2036-02-02→ Common Shares (204,000 underlying) - Award
Restricted Stock Unit
[F2][F3]2026-02-02+136,000→ 136,000 total→ Common Shares (136,000 underlying)
Footnotes (3)
- [F1]One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Each restricted stock unit represents a contingent right to receive one common share.
- [F3]One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date.